Jennifer R. Hucks MD
Asthma & COPD, Cystic Fibrosis, Pleural Disease, Restrictive Lung Disease
Assistant Professor, Internal Medicine, University of South Carolina School of Medicine, Prisma Health
Join to View Full Profile
1 Richland Medical Park DrSte 300Columbia, SC 29203
Phone+1 803-799-5022
Fax+1 803-799-5890
Dr. Hucks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Prisma HealthFellowship, Pulmonary Disease, 2008 - 2010- Prisma Health-Midlands/University of South Carolina School of Medicine-ColumbiaResidency, Internal Medicine/Pediatrics, 2004 - 2008
University of South Carolina School of MedicineClass of 2004
Certifications & Licensure
SC State Medical License 2006 - 2025
American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 21 citationsUse of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literatureMary Sheffield, Dana Nelson, Melissa O’Neal, Alyssa P. Gould, Jeannette Bouchard
International Journal of Antimicrobial Agents. 2020-11-01 - 21 citationsUse of continuous infusion ceftolozane-tazobactam with therapeutic drug monitoring in a patient with cystic fibrosis.Sarah Elizabeth B Davis, Jared Ham, Jennifer Hucks, Alyssa P. Gould, Rachel A Foster
American Journal of Health-System Pharmacy. 2019-04-08 - 10 citationsRisk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.Mohammed Al-Jaghbeer, Julie Ann Justo, William B. Owens, Joseph Kohn, P. Brandon Bookstaver
Infection. 2018-05-11
Journal Articles
- Use of continuous infusion ceftolozane–tazobactam with therapeutic drug monitoring in a patient with cystic fibrosisSarah Elizabeth Davis, Pharm.D. student, Jared Ham, Pharm.D., BCPS, Jennifer Hucks, M.D, Alyssa Gould, Pharm.D., BCIDP, Rachel Foster, Pharm.D., M.B.A., BCIDP, Julie A..., American Journal of Health-System Pharmacy, Volume 76, Issue 8, 15 April 2019, Pages 501–504, 4/8/2019
- Chronic Obstructive Pulmonary Disease: Clinical Implications for Patients with Lung CancerJennifer Hucks, Brandi R Newsome, Oncology Nursing Forum
- Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control studyMohammed J Al-Jaghbeer, Julie Ann Justo, William Owens, Joseph Kohn, P Brandon Bookstaver, Jennifer Hucks, Majdi N Al-Hasan, Infection . 2018 Aug;46(4):487-494. doi: 10.1007/s15010-018-1147-z, 8/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
